Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-DRA anticorps (AA 26-221)

HLA-DRA Reactivité: Lapin WB, IHC, IP, ICC Hôte: Cobaye Polyclonal unconjugated
N° du produit ABIN1859814
  • Antigène Voir toutes HLA-DRA Anticorps
    HLA-DRA (HLA Class II DR alpha (HLA-DRA))
    Épitope
    • 8
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 26-221
    Reactivité
    • 90
    • 17
    • 10
    • 10
    • 9
    • 9
    • 3
    • 2
    • 2
    • 1
    Lapin
    Hôte
    • 57
    • 48
    • 1
    • 1
    Cobaye
    Clonalité
    • 57
    • 50
    Polyclonal
    Conjugué
    • 55
    • 12
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Cet anticorp HLA-DRA est non-conjugé
    Application
    • 49
    • 49
    • 35
    • 33
    • 18
    • 12
    • 11
    • 10
    • 9
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Fonction
    Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
    Séquence
    MGHHHHHHSG S- AIKEE HVIIQAEYFL SPDDLGEFMF DFDGDEIFHV DMDKKETVWR LKEFGQFASF EAQGALANIA VDRANLDIMI KRSNHTPDTN VPPEVTLLPS SPVELGEPNV LICFIDKFSP PVINVTWLRN GNPVTMGVSE TVFLPRDDHL FRKFHYLPFL PSTEDVYDCK VEHWGLEEPT LKHWEFEART PLPETTENVV C
    Specificité
    The antibody is a cavia polyclonal antibody raised against HLA-DRA. It has been selected for its ability to recognize HLA-DRA in immunohistochemical staining and western blotting.
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogène
    Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) corresdonding to Ala26~Cys221 (Accession # NM_001171118.1)
    Isotype
    IgG
    Top Product
    Discover our top product HLA-DRA Anticorps primaire
  • Indications d'application

    Western blotting: 0.5-5 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.

    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Date de péremption
    24 months
  • Antigène
    HLA-DRA (HLA Class II DR alpha (HLA-DRA))
    Autre désignation
    HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA Produits)
    Synonymes
    anticorps HLA-DRA1, anticorps MLRW, anticorps DR-alpha, anticorps HLA-DRA, anticorps Mamu-DRA1, anticorps major histocompatibility complex, class II, DR alpha L homeolog, anticorps major histocompatibility complex, class II, DR alpha, anticorps hla-dra.L, anticorps HLA-DRA, anticorps MAMU-DRA, anticorps BOLA-DRA
    Sujet
    MHCDRa, HLADRa, Major Histocompatibility Complex Class II DR Alpha
    Pathways
    TCR Signaling, CXCR4-mediated Signaling Events
Vous êtes ici:
Support technique